Cargando…
Antibody response to graded dosing of coronavirus disease 2019 messenger RNA vaccines after allergic reaction to first dose
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112645/ https://www.ncbi.nlm.nih.gov/pubmed/35595005 http://dx.doi.org/10.1016/j.anai.2022.05.004 |
| _version_ | 1784709453250035712 |
|---|---|
| author | Van Meerbeke, Sara W. Fajt, Merritt L. Marini, Rachel V. Domsic, Robyn T. Petrov, Andrej A. |
| author_facet | Van Meerbeke, Sara W. Fajt, Merritt L. Marini, Rachel V. Domsic, Robyn T. Petrov, Andrej A. |
| author_sort | Van Meerbeke, Sara W. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9112645 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-91126452022-05-17 Antibody response to graded dosing of coronavirus disease 2019 messenger RNA vaccines after allergic reaction to first dose Van Meerbeke, Sara W. Fajt, Merritt L. Marini, Rachel V. Domsic, Robyn T. Petrov, Andrej A. Ann Allergy Asthma Immunol Letters American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. 2022-09 2022-05-17 /pmc/articles/PMC9112645/ /pubmed/35595005 http://dx.doi.org/10.1016/j.anai.2022.05.004 Text en © 2022 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letters Van Meerbeke, Sara W. Fajt, Merritt L. Marini, Rachel V. Domsic, Robyn T. Petrov, Andrej A. Antibody response to graded dosing of coronavirus disease 2019 messenger RNA vaccines after allergic reaction to first dose |
| title | Antibody response to graded dosing of coronavirus disease 2019 messenger RNA vaccines after allergic reaction to first dose |
| title_full | Antibody response to graded dosing of coronavirus disease 2019 messenger RNA vaccines after allergic reaction to first dose |
| title_fullStr | Antibody response to graded dosing of coronavirus disease 2019 messenger RNA vaccines after allergic reaction to first dose |
| title_full_unstemmed | Antibody response to graded dosing of coronavirus disease 2019 messenger RNA vaccines after allergic reaction to first dose |
| title_short | Antibody response to graded dosing of coronavirus disease 2019 messenger RNA vaccines after allergic reaction to first dose |
| title_sort | antibody response to graded dosing of coronavirus disease 2019 messenger rna vaccines after allergic reaction to first dose |
| topic | Letters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112645/ https://www.ncbi.nlm.nih.gov/pubmed/35595005 http://dx.doi.org/10.1016/j.anai.2022.05.004 |
| work_keys_str_mv | AT vanmeerbekesaraw antibodyresponsetogradeddosingofcoronavirusdisease2019messengerrnavaccinesafterallergicreactiontofirstdose AT fajtmerrittl antibodyresponsetogradeddosingofcoronavirusdisease2019messengerrnavaccinesafterallergicreactiontofirstdose AT marinirachelv antibodyresponsetogradeddosingofcoronavirusdisease2019messengerrnavaccinesafterallergicreactiontofirstdose AT domsicrobynt antibodyresponsetogradeddosingofcoronavirusdisease2019messengerrnavaccinesafterallergicreactiontofirstdose AT petrovandreja antibodyresponsetogradeddosingofcoronavirusdisease2019messengerrnavaccinesafterallergicreactiontofirstdose |